In one paragraphArticle in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Suting Chen *Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, affiliated Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.ORCID 0000-0002-2800-1983 Shengjuan Bao *Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, affiliated Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Jifang ZhengBeijing Key Laboratory for Drug-Resistant Tuberculosis Research, National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, affiliated Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Guanglu JiangBeijing Key Laboratory for Drug-Resistant Tuberculosis Research, National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, affiliated Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.ORCID 0000-0002-6967-552X Hongfei DuanTuberculosis Department, Beijing Chest Hospital, affiliated Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.ORCID 0000-0002-8738-5737 Hairong HuangBeijing Key Laboratory for Drug-Resistant Tuberculosis Research, National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, affiliated Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.ORCID 0000-0002-4295-4262 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Indexed as
Anti-Bacterial AgentsDrug Resistance, BacterialLung DiseasesMacrolidesMycobacterium abscessusMycobacterium Infections, NontuberculousAdultAgedAzithromycinClarithromycinFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsAzithromycinClarithromycinMacrolidesculture conversioninducible resistancemacrolidesMycobacterium abscessus complex
Identifiers
PMID40891831
PMCPMC12502594
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390